Publications by authors named "Ramos-Merino L"
Objectives: To evaluate the effectiveness of ceftaroline vs. vancomycin or daptomycin in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections (BSIs) (MRSA-BSIs).
Methods: This multicentre retrospective study conducted in 15 Spanish hospitals included data from the first MRSA-BSIs of adult patients between January 2019 and December 2022.
Article Synopsis
- A study analyzed data from 5667 patients diagnosed with infective endocarditis (IE) across 46 hospitals in Spain from 2008 to 2021, finding that only 1.7% were HIV-infected.
- HIV-infected patients tended to be younger, predominantly male, and had specific features like higher rates of tricuspid location and community-acquired infections, but fewer surgical interventions.
- Despite these differences, the study concluded that HIV status did not significantly affect in-hospital or one-year mortality rates for patients with IE.
Background And Aims: HIV-positive patients on tenofovir hydroxyl fumarate (TDF)/emtricitabine have a lower risk of COVID-19 and hospitalization than those given other treatments. Our aim was to analyze the severity of COVID-19 in patients with chronic hepatitis B (CHB) on TDF or entecavir (ETV).
Methods: Spanish hospital databases (n = 28) including information regarding adult CHB patients on TDF or ETV for the period February 1st to November 30th 2020 were searched for COVID-19, defined as a positive SARS-CoV-2 polymerase chain reaction, and for severe COVID-19.
Objective: To determine the indications, success rate and adverse effects of ceftaroline fosamil treatment in a tertiary hospital.
Methods: In total, 84 cases from February 2018 to December 2019 were retrospectively analysed. No exclusion criteria were applied.
Objective: The clinical response to ertapenem in community-acquired pneumonia (CAP) at the setting of routine hospital practice has been scarcely evaluated.
Methods: We retrospectively compared CAP cases treated with ertapenem or with other standard antimicrobials (controls) at a tertiary 1,434-bed center from 2005 to 2014.
Results: Out of 6,145 patients hospitalized with CAP, 64 (1%) ertapenem-treated and 128 controls were studied (PSI IV-V 72%, mean age 73 years.
Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period.
Arthritis Care Res (Hoboken)
July 2016
Objective: Systemic lupus erythematosus (SLE) is characterized by an unpredictable and fluctuating course. Although various methods have been developed to measure disease activity, there is still a lack of consensus about the optimal criteria for SLE remission. The principal aim of our study was to identify the number of lupus patients achieving a complete remission (implying that for 3 years there were no clinical or serologic features and no treatment with steroids and immunosuppressive drugs) in a single cohort of patients followed for a period of up to 32 years.
View Article and Find Full Text PDF